Notify me when Price Adrian files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | Common stock | 8.6% | $582,308 | 189,061 | 0% | Price Adrian | 24 Feb 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|